Trials / Withdrawn
WithdrawnNCT04361669
Hospice Quality Score Assessment Post Pharmacist Intervention
Assessing the Impact of Pharmacist Interventions on Hospice Quality Scores
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Tabula Rasa HealthCare · Industry
- Sex
- All
- Age
- 18 Years – 88 Years
- Healthy volunteers
- —
Summary
The study aims to investigate the impact of pharmacist delivered interventions on hospice patients quality metric scores.
Detailed description
The objective of this study is evaluate a program at a hospice involving activities designed to improve the site's National Quality Forum (NQF) and Consumer Assessment of Healthcare Providers and Systems (HCAHPS) scores. These scores are calculated by the hospice using existing patient satisfaction survey scores (HCAHPS). The institution quantifies their compliance with national quality metrics (NQF) and reports this existing data to the pharmacist providing counseling services to their patients. The pharmacist assesses for areas for improvement and provides additional counseling services to improve the continuity and quality of care. The pilot program is scheduled to launch April 2020 and the researchers will look to assess for changes in the NQF scores, HCAHPS scores, and time for their partnering pharmacy to refill the first set of prescriptions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Medication safety review | Implementation of a medication safety review using a clinical decision support system |
Timeline
- Start date
- 2020-04-22
- Primary completion
- 2022-09-01
- Completion
- 2022-09-01
- First posted
- 2020-04-24
- Last updated
- 2022-09-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04361669. Inclusion in this directory is not an endorsement.